CLINICAL_TRIALS
trial_result
· 2007-08-08
Clinical Trial Update: High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis [Phase 2, Phase 3]
Summary
Phase 2/3 trial evaluating high-dose isoniazid as adjuvant therapy for multidrug-resistant tuberculosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GSVM Medical College | Conditions: Tuberculosis, Multidrug-Resistant | Phase 2, Phase 3 | Status: COMPLETED